- Investing Ideas
- Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
13
Mid-Large Cap Stocks
13 companies
Roche Holding
Market Cap: CHF 255.0b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 318.60
7D
-2.3%
1Y
22.3%
Novartis
Market Cap: CHF 216.6b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 120.28
7D
0.05%
1Y
26.5%
Tecan Group
Market Cap: CHF 1.9b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 150.40
7D
0.8%
1Y
-5.6%
Bachem Holding
Market Cap: CHF 5.1b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 66.90
7D
0.5%
1Y
16.8%
Sandoz Group
Market Cap: CHF 29.4b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 69.44
7D
3.6%
1Y
61.0%
Cosmo
Market Cap: CHF 1.1b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 66.80
7D
-5.9%
1Y
18.7%
SKAN Group
Market Cap: CHF 1.1b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 48.85
7D
-2.3%
1Y
-30.8%
Galderma Group
Market Cap: CHF 40.4b
Operates as a dermatology company worldwide.
GALD
CHF 173.70
7D
0.4%
1Y
56.1%
Dottikon ES Holding
Market Cap: CHF 4.2b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries.
DESN
CHF 286.00
7D
-4.0%
1Y
-0.9%
Lonza Group
Market Cap: CHF 34.8b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 500.40
7D
1.1%
1Y
-10.8%
Siegfried Holding
Market Cap: CHF 3.0b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 68.55
7D
-5.3%
1Y
-26.9%
Idorsia
Market Cap: CHF 1.4b
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 5.77
7D
24.0%
1Y
208.2%
PolyPeptide Group
Market Cap: CHF 1.3b
Operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally.
PPGN
CHF 38.75
7D
15.2%
1Y
95.7%